Luis E. Raez: Analysis of PRO data from the landmark LIBRETTO-001 trial

Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post on X:

“In this analysis of PRO data from the landmark LIBRETTO-001 trial published by Alexander Drilon, Vivek Subbiah, Benjamin Besse, Ben Solomon, Keunchil Park, Herbert Loong and others, the majority of patients with RET cancers that we treated remained stable or improved demonstrating the favorable HRQoL during long-term treatment with selpercatinib.”

Read further.
Source: Luis E. Raez/X